Shimamori, Y.; Mitsunaka, S.; Yamashita, H.; Suzuki, T.; Kitao, T.; Kubori, T.; Nagai, H.; Takeda, S.; Ando, H.
Staphylococcal Phage in Combination with Staphylococcus epidermidis as a Potential Treatment for Staphylococcus aureus-Associated Atopic Dermatitis and Suppressor of Phage-Resistant Mutants. Viruses 2021, 13, 7.
https://doi.org/10.3390/v13010007
AMA Style
Shimamori Y, Mitsunaka S, Yamashita H, Suzuki T, Kitao T, Kubori T, Nagai H, Takeda S, Ando H.
Staphylococcal Phage in Combination with Staphylococcus epidermidis as a Potential Treatment for Staphylococcus aureus-Associated Atopic Dermatitis and Suppressor of Phage-Resistant Mutants. Viruses. 2021; 13(1):7.
https://doi.org/10.3390/v13010007
Chicago/Turabian Style
Shimamori, Yuzuki, Shoichi Mitsunaka, Hirotaka Yamashita, Tohru Suzuki, Tomoe Kitao, Tomoko Kubori, Hiroki Nagai, Shigeki Takeda, and Hiroki Ando.
2021. "Staphylococcal Phage in Combination with Staphylococcus epidermidis as a Potential Treatment for Staphylococcus aureus-Associated Atopic Dermatitis and Suppressor of Phage-Resistant Mutants" Viruses 13, no. 1: 7.
https://doi.org/10.3390/v13010007
APA Style
Shimamori, Y., Mitsunaka, S., Yamashita, H., Suzuki, T., Kitao, T., Kubori, T., Nagai, H., Takeda, S., & Ando, H.
(2021). Staphylococcal Phage in Combination with Staphylococcus epidermidis as a Potential Treatment for Staphylococcus aureus-Associated Atopic Dermatitis and Suppressor of Phage-Resistant Mutants. Viruses, 13(1), 7.
https://doi.org/10.3390/v13010007
